Endpoint security versus productivity in the pharmaceutical industry: a false choice?
Computing's interviews with CIOs and CISOs consistently support the view that breaches are inevitable, and it is a consistent finding in both research and the recent history of the pharmaceutical sector in the UK.
Before anyone had heard the term COVID-19, the pharmaceutical industry was already a highly attractive target for attackers. It is an industry built on huge investments in the development of specific drugs, and the intellectual property (IP) on these drugs can be worth alot. However, since the industry has been front and centre in the global battle against COVID-19, both in terms of treatments and vaccine development. This has inevitably increased its value as a target.
The results shown in this research paper are drawn from a survey covering 100 IT professionals with responsibility for security strategy or implementation in pharmaceutical companies.
Download now to learn why the pharmaceutical industry does not have to choose between the securing of endpoints and the productivity of users – and security teams.
Read More
By submitting this form you agree to BlackBerry contacting you with marketing-related emails or by telephone. You may unsubscribe at any time. BlackBerry web sites and communications are subject to their Privacy Notice.
By requesting this resource you agree to our terms of use. All data is protected by our Privacy Notice. If you have any further questions please email dataprotection@techpublishhub.com
Related Categories: AIM, Applications, Cloud, Collaboration, Email, Embedded Systems, Endpoint Security, ERP, Malware, Mobile Devices, Network, SAN
More resources from BlackBerry
The Evolution and Arrival of the Prevention-F...
A few years ago, a proactive prevention-based security posture was more an aspiration than a reality. The breakthrough came in 2012, when a group o...
The Zero Trust Guide To Remote Worker Securit...
With the recent increase in the number of employees working from home as a result of the COVID-19 outbreak, the enterprise network has effectively ...
Next-Generation Anti-Malware Testing For Dumm...
How did you choose your anti-malware solution? Did you put it through the same rigorous process as your other security solutions? Or, did you simpl...
